Skip to main content
SpringerLink
Log in

Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Patients with chronic renal failure undergoing periodic maintenance hemodialysis frequently present dyslipoproteinaemia which has been linked to the sharply increased risk of cardiovascular disease in these subjects. Reported defects on lipoprotein-related enzyme activities suggest a possible influence of hemodialysis not just to plasma lipid and lipoprotein levels but also to the composition of cell membranes. In this study, it was investigated whether the reported lipid abnormalities are accompanied by changes in serum phospholipids levels. Blood samples were obtained from 140 patients undergoing maintenance hemodialysis treatment and 122 normolipidemic healthy controls and analyzed for total serum phospholipids and their individual subclasses, as well as for total cholesterol and triglycerides, HDL-cholesterol and its subclasses. A significant decrease was observed in serum HDL cholesterol levels (p < 0.001) and its subclasses, HDL2-cholesterol (p < 0.01) and HDL3-cholesterol (p < 0.01) in patients when compared with healthy controls. A critical increase in the serum triglyceride content (p < 0.001) of patients was also observed. In addition, the serum levels of sphingomyelin (p < 0.01) and diphosphatidylglycerol (p < 0.001) were increased in the patient group, while the levels of phosphatidylcholine (p < 0.01) and phosphatidylinositol (p < 0.01) were significantly decreased in the patient group compared to healthy controls. In conclusion, this work clearly demonstrates that hemodialysis treatment contributes significantly to the dyslipidemic profile of end-stage renal failure patients by altering serum lipoprotein and phospholipids concentrations. (Mol Cell Biochem 265: 57–61, 2004)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Attman PO, Samuelsson O, Alaupovic P: Lipoprotein metabolism in renal failure. Am J Kidney Dis 21: 573–592, 1993

    Google Scholar 

  2. Kasiske B: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32: S142–S156, 1998

    Google Scholar 

  3. Levey A, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32: 853–906, 1998

    Google Scholar 

  4. Wanner C: Importance of hyperlipidaemia and therapy in renal patients. Nephrol Dial Transplant 15: S92–S96, 2000

    Google Scholar 

  5. Wheeler DC, Bernard DB: Lipid abnormalities in the nephritic syn-drome: Causes, consequences and treatment. Am J Kidney Dis 23: 331–346, 1994

    Google Scholar 

  6. Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inque T, Morii H: Atherogenic lipoprotein changes in the absence of hy-perlipidemia in patients with chronic renal failure treated by hemodial-ysis. Atherosclerosis 131: 229–236, 1997

    Google Scholar 

  7. Oi K, Hirano T, Sakai S, Kawaguchi Y, Hosaya T: Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int 56: S227–S228, 1999

    Google Scholar 

  8. Gillett MPT, Teixeira V, Dimenstein R: Decreased plasma lecithin: Cholesterol acyltransfer and associated changes in plasma and red cell lipids in uraemia. Nephrol Dial Transplant 8: 407–411, 1993

    Google Scholar 

  9. Gillett MPT, Obineche EN, El-Rokhaimi M, Lakhani MS, Abdulle A, Sulaiman M: Lecithin: Cholesterol acyltransfer, dyslipoproteinemia and membrane lipids in uraemia. J Nephrol 14: 472–480, 2001

    Google Scholar 

  10. Ordonez JD, Haitt RA, Killbrew EJ, Firman BH: The increased risk of coronary heart disease associated with nephritic syndrome. Kidney Int 44: 638–642, 1993

    Google Scholar 

  11. Chan MK, Varghese Z, Morrhead JF: Lipid abnormalities in uraemia, dialysis and transplantation. Kidney Int 44: 638–642, 1981

    Google Scholar 

  12. Kšsniger M, Quaschning T, Wanner C, Schollmeyer P, KrŠmer-Guth A: Abnormalities in lipoprotein metabolism in hemodialysis patients. Kidney Int 56: S248–S250, 1999

    Google Scholar 

  13. Tutor JC, Par JM, Areses J, Garcia F: Detrmination of high-density lipoprotein phospholipids and its possible clinical application in the assessment of cardiovascular disease risk. Biometrica VI2: 65, 1981

    Google Scholar 

  14. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic deter-mination of total serum cholesterol. Clin Chem 20: 470–475, 1974

    Google Scholar 

  15. Wahalefed AW: Triglyceride determination after enzymatic hydrolysis. In: HU Bermeyer (ed). Methods of Enzymatic Analysis, Vol 4, Aca-demic Press, New York, 1974, pp 1831–1835

    Google Scholar 

  16. Lopez-Virella HF, Stone P, Ellis J, Coltwell LA: Cholesterol determi-nation in the HDL separated by precipitation with polyanions. J Lipid Res 11: 583–595, 1970

    Google Scholar 

  17. Friedwald WT, Levy RI, Fredrikson DS: Estimation of the concentra-tion of low density lipoprotein cholesterol in plasma, without use of preparative ultracentifugation. Clin Chem 18: 499–502, 1972

    Google Scholar 

  18. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA: Separation and quantitation of subclasses of human plasma high-density lipopro-teins by a simple precipitation procedure. J Lipid Res 23: 1206–1223, 1982

    Google Scholar 

  19. Folch J, Lees Mand Sloane-Stanley HG: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497–509, 1957

    Google Scholar 

  20. Kalofoutis A, Jullien J, Miras A: Influence of long-term exercise and training on heart and liver phospholipids in rats. Int J Biochem 5: 767–711, 1974

    Google Scholar 

  21. Kwiterovich RO, Sloan MR, Fredrikson MS: Glycolipids and other lipid constituents of normal human liver. J Lipid Res II: 322–330, 1970

    Google Scholar 

  22. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 234: 466–468, 1959

    Google Scholar 

  23. Cano N, Coeyerehourq LC, Lacombe P: Perdialytic parenteral nutrition with lipids and amino acids to malnourished hemodialysis patients. Am J Clin Nutr 52: 726–730, 1990

    Google Scholar 

  24. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Impaired high-density lipoprotein metabolism in uremic patients. Kideny Int 41: 1653–1661, 1992

    Google Scholar 

  25. Dieplinger H, Schoenfeld PY, Fielding CJ: Plasma cholesterol metab-olism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. J Clin Invest 77: 1071–1083, 1986

    Google Scholar 

  26. Fleisher S, Bock HG, Gazzoti P. In: A. Klingerberg, G.F. Azzont (eds). Membrane Proteins in Transport and Phosphorylation, North Holland, Amsterdam, 1974, pp 125

  27. Niggli V, Adunyah ES, Penniston JT, Carafoli E: Purified (Ca 2 +-Mg 2 +)-ATPase of the erythrocyte membrane. Reconstitution and effect of calmodulin and phospholipids. J Biol Chem 256: 395–401, 1981

    Google Scholar 

  28. Koval M, Pagano RE: Intracellular transport and metabolism of sphingomyelin. Biochim Biophys Acta 1082: 113–125, 1991

    Google Scholar 

  29. Jones LM, Michell RH: The relationship of calcium to receptor-controlled stimulation of phosphatidylinositol turnover. Effects of acetylcholine, adrenaline, calcium ions, cinchocaine and a bivalent cation ionophore on rat parotid-gland fragments. Biochem J 148: 479–485, 1975

    Google Scholar 

  30. Stahl WL: Role of phospholipids in the NA, K-stimulated adenosine triphosphatase system of brain microsomes. Arch Biochem Biophys 154: 56–67, 1973

    Google Scholar 

  31. Das ML, Haak ED, Crane FL: Proteolipids. IV. Formation of complexes between cytochrome c and purified phospholipids. Biochemistry 41: 859–865, 1965

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Chemistry, University of Athens, School of Medicine, Athens, Greece

    C. Piperi, C. Kalofoutis, M. Tzivras, T. Troupis, A. Skenderis & A. Kalofoutis

Authors
  1. C. Piperi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Kalofoutis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Tzivras
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Troupis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Skenderis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Kalofoutis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piperi, C., Kalofoutis, C., Tzivras, M. et al. Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients. Mol Cell Biochem 265, 57–61 (2004). https://doi.org/10.1023/B:MCBI.0000044315.74038.78

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000044315.74038.78

Search

Navigation